Sodium Nitrate to Improve Blood Flow

Status Completed

Clinical Trial Summary

Investigators recently showed that tadalafil restores functional sympatholysis in patients with Becker muscular dystrophy (BMD). If tadalafil restores functional sympatholysis in BMD via the NO-cyclic guanosine monophosphate pathway, then functional sympatholysis should also be restored by sodium nitrite— which is an indirect nitric oxide donor.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02847975
Study type	Interventional
Source	Cedars-Sinai Medical Center
Contact
Status	Completed
Phase	Phase 1
Start date	October 2013
Completion date	December 2014

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01168908` - Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy	Phase 2
Recruiting	`NCT01484678` - Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
Completed	`NCT02147639` - Effects of Sodium Nitrate on Blood Flow in Becker Muscular Dystrophy	Phase 2/Phase 3
Recruiting	`NCT02069756` - The Duchenne Registry
Completed	`NCT04585464` - A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults	Phase 1
Recruiting	`NCT04668716` - Brain Involvement in Dystrophinopathies Part 2
Completed	`NCT03236662` - (-)- Epicatechin Becker Muscular Dystrophy	Phase 2
Completed	`NCT01350154` - Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy Patients	Phase 2
Enrolling by invitation	`NCT06066580` - Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy	Phase 2
Not yet recruiting	`NCT06363526` - Effectiveness of 5-week Digital Respiratory Practice in a Group of Children With Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.	N/A
Recruiting	`NCT05409079` - Schulze Muscular Dystrophy Ability Clinical Study	N/A
Completed	`NCT01856868` - Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)	Phase 1/Phase 2
Completed	`NCT01557400` - Study of Ataluren for Previously Treated Participants With Nonsense Mutation Duchenne/Becker Muscular Dystrophy (nmDBMD) in Europe, Israel, Australia, and Canada	Phase 3
Recruiting	`NCT02109692` - Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies	N/A
Recruiting	`NCT03057002` - UTSW HP [13-C] Pyruvate Injection in HCM
Recruiting	`NCT04583917` - Brain Involvement in Dystrophinopathies Part 1
Completed	`NCT02207283` - PDE5 Inhibition to Alleviate Functional Muscle Ischemia in Becker Muscular Dystrophy	Phase 4
Withdrawn	`NCT03076814` - Functional Muscle Ischemia With Tadalafil Treatment in Becker Muscular Dystrophy	N/A
Completed	`NCT00873782` - Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy	Phase 1
Not yet recruiting	`NCT05715957` - Follow-up Study on Female Carriers With DMD Gene Variants